| | | | | 1 | | | |
| | | | | 7 | | | |
| | | | | 8 | | | |
| | | | | 10 | | | |
| | | | | 10 | | | |
| | | | | 10 | | | |
| | | | | 10 | | | |
| | | | | 10 | | | |
| | | | | 12 | | | |
| | | | | 13 | | | |
| | | | | 13 | | | |
| | | | | 14 | | | |
| | | | | 14 | | | |
| | | | | 15 | | | |
| | | | | 16 | | | |
| | | | | 16 | | | |
| | | | | 16 | | | |
| | | | | 17 | | | |
| | | | | 18 | | | |
| | | | | 19 | | | |
| | | | | 20 | | | |
| | | | | 21 | | | |
| | | | | 23 | | | |
| | | | | 27 | | | |
| | | | | 30 | | | |
| | | | | 37 | | | |
| | | | | 45 | | | |
| | | | | 47 | | | |
| | | | | 47 | | | |
| | | | | 47 | | | |
| | | | | 48 | | | |
| | | | | A-1 | | | |
| | | | | B-1 | | | |
| | | | | C-1 | | |
Name
|
| |
Age
|
| |
Position
|
| |
Served as a
Director Since |
|
Klaas de Boer | | |
58
|
| |
Director
|
| |
2021
|
|
Sri Peruvemba | | |
58
|
| |
Director
|
| |
2023
|
|
Name
|
| |
Age
|
| |
Position(s)
|
| |
Served as an Officer or
Director Since |
|
Class I Director: | | | | | | | | | | |
Steven DenBaars | | |
61
|
| | Director | | |
2022
|
|
Class III Directors: | | | | | | | | | | |
Ian Jenks | | |
69
|
| | Chairman of the Board and Chief Executive Officer | | |
2021
|
|
Barbra C. Keck | | |
45
|
| | Chief Financial Officer and Director | | |
2021
|
|
Name
|
| |
Age
|
| |
Position(s)
|
| |
Serving in
Position Since |
|
Ian Jenks | | |
69
|
| | Chairman of the Board and Chief Executive Officer | | |
2017
|
|
Barbra Keck | | |
45
|
| | Chief Financial Officer and Director | | |
2022
|
|
Beverley Brown, Ph.D. | | |
61
|
| | Chief Scientist | | |
2014
|
|
Simon Ogier, Ph.D. | | |
50
|
| | Chief Technology Officer | | |
2019
|
|
Officer Name and Principal Position
|
| |
Year
|
| |
Salary
|
| |
Bonus
|
| |
Option
Awards(1) |
| |
All Other
Compensation(2) |
| |
Total
|
| ||||||||||||||||||
| | | | | | | | |
$
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
| |||||||||||||||
Ian Jenks
|
| | | | 2022 | | | | | | 313,500 | | | | | | 76,500 | | | | | | 156,840 | | | | | | 22,093 | | | | | | 568,933 | | |
Chief Executive Officer
|
| | | | 2021 | | | | | | 294,379 | | | | | | 179,881 | | | | | | 611,775 | | | | | | 20,787 | | | | | | 1,106,822 | | |
Beverly Brown(3)
|
| | | | 2022 | | | | | | 217,163 | | | | | | 41,053 | | | | | | 47,052 | | | | | | — | | | | | | 305,268 | | |
Chief Scientist
|
| | | | 2021 | | | | | | 236,101 | | | | | | 74,321 | | | | | | 543,617 | | | | | | — | | | | | | 854,039 | | |
Simon Ogier
|
| | | | 2022 | | | | | | 165,051 | | | | | | 60,575 | | | | | | 191,180 | | | | | | 12,033 | | | | | | 428,838 | | |
Chief Technology Officer
|
| | | | 2021 | | | | | | 163,790 | | | | | | 20,474 | | | | | | — | | | | | | 9,830 | | | | | | 194,094 | | |
| | | | | | | | |
Option Awards
|
| | | | | | | | | | |||||||||
| | | | | | | | |
Number of Securities Underlying
Unexercised Options (#) |
| |
Option
Exercise Price ($) |
| |
Option
Expiration Date(1) |
| ||||||||||||
Name
|
| |
Grant Date
|
| |
Type
|
| |
Exercisable
|
| |
Unexercisable
|
| |||||||||||||||
Ian Jenks
|
| |
3/31/2021
|
| |
ISO
|
| | |
|
261,241
|
| | | |
|
335,884
|
| | | |
$
|
2.00
|
| | |
3/31/2031
|
|
|
07/08/2022
|
| |
ISO
|
| | |
|
—
|
| | | |
|
150,000
|
| | | |
$
|
2.00
|
| | |
07/08/2032
|
| ||
Beverly Brown(2)
|
| |
2/23/2021
|
| |
NQSO
|
| | |
|
178,086
|
| | | |
|
—
|
| | | |
$
|
0.001
|
| | |
2/23/2031
|
|
|
3/31/2021
|
| |
ISO
|
| | |
|
81,633
|
| | | |
|
104,968
|
| | | |
$
|
2.00
|
| | |
3/31/2031
|
| ||
|
07/08/2022
|
| |
NQSO
|
| | |
|
—
|
| | | |
|
45,000
|
| | | |
$
|
2.00
|
| | |
07/08/2032
|
| ||
Simon Ogier
|
| |
3/31/2021
|
| |
EMI
|
| | |
|
81,633
|
| | | |
|
104,969
|
| | | |
$
|
2.00
|
| | |
3/31/2031
|
|
|
07/08/2022
|
| |
NQSO
|
| | |
|
—
|
| | | |
|
45,000
|
| | | |
$
|
2.00
|
| | |
07/08/2032
|
|
Director Name
|
| |
Year
|
| |
Cash
Compensation |
| |
Stock
Option Awards(1) |
| |
All Other
Compensation |
| |
Total
|
| |||||||||||||||
| | | | | | | | |
$
|
| |
$
|
| |
$
|
| |
$
|
| ||||||||||||
Barbra Keck(2)
|
| | | | 2022 | | | | | | 34,239(3) | | | | | | 6,274 | | | | | | —(4) | | | | | | 40,513 | | |
Klaas de Boer(5)
|
| | | | 2022 | | | | | | 36,000 | | | | | | 6,274 | | | | | | — | | | | | | 42,274 | | |
Steven DenBaars(6)
|
| | | | 2022 | | | | | | 18,000 | | | | | | 18,821 | | | | | | — | | | | | | 36,821 | | |
Simon King(7)
|
| | | | 2022 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Plan category
|
| |
Number of securities
to be issued upon exercise of outstanding options, warrants and rights (a) |
| |
Weighted average
exercise price of outstanding options, warrants and rights (b) |
| |
Number of securities
remaining available for future issuance under equity compensation plans (excluding securities reflected in column a) (c)(2) |
| |||||||||
Equity compensation plans approved by security holders(1)
|
| | | | 2,829,756 | | | | | $ | 1.81 | | | | | | 447,607 | | |
Equity compensation plans not approved by
security holders |
| | | | — | | | | | | — | | | | | | — | | |
Total
|
| | | | 2,829,756 | | | | | $ | 1.81 | | | | | | 447,607 | | |
Name of Beneficial Owner
|
| |
Shares of Common Stock
Beneficially Owned (#) |
| |
Percentage of
Common Stock Beneficially Owned (%) |
| ||||||
5% Stockholders: | | | | | | | | | | | | | |
Octopus Investments Limited, 33 Holborn, London EC1N 2HT(1)
|
| | | | 7,476,028 | | | | | | 25.3 | | |
Entrepreneurs Fund LP, 2nd Floor, Windward House,
La Route de la Liberation, St Helier, Jersey, JE2 3BQ, The Channel Islands(2) |
| | | | 3,585,252 | | | | | | 12.1 | | |
Orin Hirschman, 6006 Berkeley Ave., Baltimore, MD 21209(3)
|
| | | | 2,955,818 | | | | | | 9.99 | | |
Mark Tompkins Apt. 1, Via Guidino 23, 6900 Lugano-Paradiso Switzerland
|
| | | | 2,292,162 | | | | | | 7.7 | | |
The Hewlett Fund LP, 100 Merrick Road, Suite 400W, Rockville Centre, NY 11570(4)
|
| | | | 2,955,818 | | | | | | 9.99 | | |
Named Executive Officers and Directors: | | | | | | | | | | | | | |
Ian Jenks(5)
|
| | | | 1,038,393 | | | | | | 3.5 | | |
Barbra C. Keck(6)
|
| | | | 12,625 | | | | | | * | | |
Beverley Brown(7)
|
| | | | 323,951 | | | | | | 1.1 | | |
Simon Ogier(8)
|
| | | | 323,951 | | | | | | 1.1 | | |
Klaas de Boer(9)
|
| | | | 612,625 | | | | | | 2.1 | | |
Steven DenBaars(10)
|
| | | | 30,250 | | | | | | * | | |
Sri Peruvemba(11)
|
| | | | 66,029 | | | | | | * | | |
All directors and current executive officers as a group (7 persons)
|
| | | | 2,407,824 | | | | | | 8.1 | | |
| | |
For the Years End December 31,
|
| |||||||||
US$(000)
|
| |
2022
|
| |
2021
|
| ||||||
Audit fees
|
| | | $ | 368 | | | | | $ | 456 | | |
Audit-related fees
|
| | | | — | | | | | | — | | |
Tax fees
|
| | | | — | | | | | | 10 | | |
All other fees
|
| | | | — | | | | | | — | | |
Total
|
| | | $ | 368 | | | | | $ | 466 | | |
| | |
Current
|
| |
1:30
|
| |
1:40
|
| |
1:50
|
| |
1:60
|
| |||||||||||||||
Common Stock Authorized(1)
|
| | | | 300,000,000 | | | | | | 300,000,000 | | | | | | 300,000,000 | | | | | | 300,000,000 | | | | | | 300,000,000 | | |
Common Stock Issued and
Outstanding |
| | | | 29,587,773 | | | | | | 986,260 | | | | | | 739,695 | | | | | | 591,759 | | | | | | 493,130 | | |
Number of Shares of Common Stock Reserved for Issuance(2)
|
| | | | 152,113,201 | | | | | | 5,070,444 | | | | | | 3,802,833 | | | | | | 3,042,268 | | | | | | 2,535,225 | | |
Number of Shares of Common Stock Authorized but Unissued and Unreserved
|
| | | | 118,299,026 | | | | | | 293,943,296 | | | | | | 295,457,472 | | | | | | 296,365,976 | | | | | | 296,971,645 | | |
Price per share, based on the closing price of our Common Stock on July 14, 2023(3)
|
| | | $ | 0.22 | | | | | $ | 6.60 | | | | | $ | 8.80 | | | | | $ | 11.00 | | | | | $ | 13.20 | | |